Form 4 for AGEN AGENUS INC
Accepted 2021-07-02 00:00:00 ET · period of report 2021-06-15 · accession 0000899243-21-027356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-02 | 2021-06-30 | AGEN | Buell Jennifer | COO, Pres | A - Grant | $5.49 | +10.6K | 127.1K | +9% | +$58.2K |
| D | 2021-07-02 | 2021-06-15 | AGEN | Buell Jennifer | COO, Pres | A - Grant | $0.00 | +900.0K | 900.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | A | A | 10,597 | $5.49 | 127,091 | D | — | — | (F1) The stock issued is fully-vested on the date of issuance, but is subject to a 12-month lockup restriction. |
| 2 | Derivative | Stock Option | 2021-06-15 | A | A | 900,000 | $0.00 | 900,000 | D | $3.18 · — to 2030-12-17 | 900,000 Common Stock | (F2) Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests over a four-year period, with 1/3 of Option vesting on December 17, 2022, and the balance vesting in eight equal quarterly installments thereafter. |